Nephron Assumes Humana (HUM) at Hold
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
Tweet
Share
E-mailGet Alerts HUM Hot Sheet
Price: $433.50 --0%
Rating Summary:
19 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 15
Rating Summary:
19 Buy, 16 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 10 | New: 15
Join SI Premium – FREE
Nephron analyst Eric P assumes coverage on Humana (NYSE: HUM) with a Hold rating and a price target of $200.00.
For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.
Shares of Humana closed at $205.14 yesterday.
You May Also Be Interested In
- Raymond James Upgrades Humana (HUM) to Outperform
- JPMorgan Upgrades Rumo SA (RAIL3:BZ) to Overweight
- Morgan Stanley Resumes Poste Italiane SpA (PST:IM) (PITAF) at Overweight
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
